- Home
- ANGH vs DYAI Comparison
ANGH vs DYAI Comparison
Compare ANGH & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- DYAI
- Stock Information
- Founded
- ANGH 2012
- DYAI 1979
- Country
- ANGH United Arab Emirates
- DYAI United States
- Employees
- ANGH N/A
- DYAI N/A
- Industry
- ANGH Telecommunications Equipment
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANGH Consumer Discretionary
- DYAI Health Care
- Exchange
- ANGH Nasdaq
- DYAI Nasdaq
- Market Cap
- ANGH 32.1M
- DYAI 28.3M
- IPO Year
- ANGH N/A
- DYAI 2004
- Fundamental
- Price
- ANGH $0.48
- DYAI $0.98
- Analyst Decision
- ANGH
- DYAI Strong Buy
- Analyst Count
- ANGH 0
- DYAI 1
- Target Price
- ANGH N/A
- DYAI $6.00
- AVG Volume (30 Days)
- ANGH 11.5K
- DYAI 63.9K
- Earning Date
- ANGH 07-22-2025
- DYAI 08-12-2025
- Dividend Yield
- ANGH N/A
- DYAI N/A
- EPS Growth
- ANGH N/A
- DYAI N/A
- EPS
- ANGH N/A
- DYAI N/A
- Revenue
- ANGH $78,093,405.00
- DYAI $3,554,344.00
- Revenue This Year
- ANGH N/A
- DYAI $22.56
- Revenue Next Year
- ANGH N/A
- DYAI $30.95
- P/E Ratio
- ANGH N/A
- DYAI N/A
- Revenue Growth
- ANGH 88.72
- DYAI 57.59
- 52 Week Low
- ANGH $0.42
- DYAI $0.91
- 52 Week High
- ANGH $1.08
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- ANGH 45.12
- DYAI 53.08
- Support Level
- ANGH $0.47
- DYAI $0.91
- Resistance Level
- ANGH $0.52
- DYAI $0.99
- Average True Range (ATR)
- ANGH 0.02
- DYAI 0.06
- MACD
- ANGH 0.00
- DYAI 0.01
- Stochastic Oscillator
- ANGH 42.86
- DYAI 59.93
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.